TSXV - Delayed Quote CAD

Voyageur Pharmaceuticals Ltd. (VM.V)

Compare
0.2400
+0.0300
+(14.29%)
At close: January 28 at 3:59:59 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Mr. Brent Willis Bsc.Eng President, CEO & Director 132k -- 1971
Mr. Bradley Craig Willis P.Eng. Founder, COO & Director 126k -- 1971
Mr. Albert Deslauriers Chief Financial Officer 105.6k -- --
Dr. Iryna Saranchova M.D., Ph.D. Chief Scientific Officer -- -- --

Voyageur Pharmaceuticals Ltd.

4103B Center Street
Calgary, AB T2E 2Y6
Canada
https://voyageurpharmaceuticals.ca
Sector: 
Healthcare

Description

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah. It develops barium, iodine-based APIs, and imaging contrast agents for medical radiology. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.

Corporate Governance

Voyageur Pharmaceuticals Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

March 7, 2017 at 12:00 AM UTC

Dividend Date

Related Tickers